Literature DB >> 7525990

Role of RNA in enzymatic activity of the reverse transcriptase of hepatitis B viruses.

G H Wang1, F Zoulim, E H Leber, J Kitson, C Seeger.   

Abstract

The hepadnavirus reverse transcriptase is a multifunction enzyme. In addition to its role in DNA synthesis, the polymerase is required for RNA packaging and also functions as the primer for minus-strand DNA synthesis. Previously, we demonstrated that the protein-priming activity of the polymerase requires a viral RNA segment, termed epsilon, which serves as a template for the synthesis of a short DNA oligomer that is covalently attached to the reverse transcriptase (G.-H. Wang and C. Seeger, J. Virol. 67:6507-6512, 1993). We now report that epsilon is sufficient for activation of the reverse transcriptase to prime DNA synthesis through the formation of a stable RNA-protein (RNP) complex. We also demonstrate that the binding reaction depends on sequence-specific determinants on epsilon. Moreover, our results indicate that two genetically separated domains of the reverse transcriptase are required for formation of the RNP complex. Finally, we show that the polymerase has a DNA polymerase activity in the absence of epsilon which does not depend on the protein-priming mechanism.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7525990      PMCID: PMC237319     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  cis-acting sequences required for encapsidation of duck hepatitis B virus pregenomic RNA.

Authors:  R C Hirsch; D D Loeb; J R Pollack; D Ganem
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

2.  Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as wel as for reverse transcription.

Authors:  R C Hirsch; J E Lavine; L J Chang; H E Varmus; D Ganem
Journal:  Nature       Date:  1990-04-05       Impact factor: 49.962

3.  Novel mechanism for reverse transcription in hepatitis B viruses.

Authors:  G H Wang; C Seeger
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

4.  Biosynthesis of the reverse transcriptase of hepatitis B viruses involves de novo translational initiation not ribosomal frameshifting.

Authors:  L J Chang; P Pryciak; D Ganem; H E Varmus
Journal:  Nature       Date:  1989-01-26       Impact factor: 49.962

5.  HIV-1 Tat protein trans-activates transcription in vitro.

Authors:  R A Marciniak; B J Calnan; A D Frankel; P A Sharp
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

6.  Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function.

Authors:  S J Madore; B R Cullen
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

7.  The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation.

Authors:  R Bartenschlager; M Junker-Niepmann; H Schaller
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

8.  Naturally occurring point mutation in the C terminus of the polymerase gene prevents duck hepatitis B virus RNA packaging.

Authors:  Y Chen; W S Robinson; P L Marion
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

9.  A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA.

Authors:  M Junker-Niepmann; R Bartenschlager; H Schaller
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598

10.  The amino-terminal domain of the hepadnaviral P-gene encodes the terminal protein (genome-linked protein) believed to prime reverse transcription.

Authors:  R Bartenschlager; H Schaller
Journal:  EMBO J       Date:  1988-12-20       Impact factor: 11.598

View more
  54 in total

1.  In vitro reconstitution of functional hepadnavirus reverse transcriptase with cellular chaperone proteins.

Authors:  Jianming Hu; David Toft; Dana Anselmo; Xingtai Wang
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Distinct requirement for two stages of protein-primed initiation of reverse transcription in hepadnaviruses.

Authors:  Xingtai Wang; Jianming Hu
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

3.  Heat shock protein 90-independent activation of truncated hepadnavirus reverse transcriptase.

Authors:  Xingtai Wang; Xiaofeng Qian; Hwai-Chen Guo; Jianming Hu
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

4.  Expression of hTERT and hTR in cis reconstitutes and active human telomerase ribonucleoprotein.

Authors:  F Bachand; G Kukolj; C Autexier
Journal:  RNA       Date:  2000-05       Impact factor: 4.942

5.  In vitro reconstitution of a functional duck hepatitis B virus reverse transcriptase: posttranslational activation by Hsp90.

Authors:  J Hu; D Anselmo
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 6.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

7.  Effects of mutations within and adjacent to the terminal repeats of hepatitis B virus pregenomic RNA on viral DNA synthesis.

Authors:  S Perri; D Ganem
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

8.  Mapping of the hepatitis B virus reverse transcriptase TP and RT domains by transcomplementation for nucleotide priming and by protein-protein interaction.

Authors:  R E Lanford; Y H Kim; H Lee; L Notvall; B Beames
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

9.  Distinct requirements for primary sequence in the 5'- and 3'-part of a bulge in the hepatitis B virus RNA encapsidation signal revealed by a combined in vivo selection/in vitro amplification system.

Authors:  A Rieger; M Nassal
Journal:  Nucleic Acids Res       Date:  1995-10-11       Impact factor: 16.971

10.  The duck hepatitis B virus polymerase is activated by its RNA packaging signal, epsilon.

Authors:  J E Tavis; B Massey; Y Gong
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.